Skip to main content

Table 1 General characteristics of the studied series, according to newly diagnosis or follow-up patient groups

From: Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?

Characteristics Total (n = 790, 100.0%) Newly diagnosed (n = 124, 15.7%) Follow-up (n = 666, 84.3%) P value
Age (SD), years 44.4 (13.1) 41.7 (13.0) 44.9 (13.1) 0.016
Ranges:     
19-35 years 25.7% 36.8% 23.6% 0.025
36-50 years 40.8% 36.8% 41.7%  
51-65 years 26.0% 19.3% 27.2%  
> 65 years 7.4% 7.0% 7.5%  
Gender (female) 68.9% 63.7% 69.8% NS
Diagnosis delay (SD), years 2.3 (4.9) 2.2 (4.6) 2.3 (5.0) NS
Body mass index, kg/m2 24.8 (4.0) 24.2 (3.3) 25.0 (4.1) 0.018
Drug intake at time of the study visit (n):     
Average 2.4 (1.2) 1.8 (1.2) 2.5 (1.2) < 0.001
1 26.0% 55.4% 22.7% < 0.001
2 33.3% 24.6% 34.3%  
3 21.3% 6.2% 23.0%  
4 14.5% 9.2% 15.1%  
5 or more 4.9% 4.6% 4.9%  
Drug intake at the time of the study visit (class):     
Benzodiazepines 49.3% 72.9% 47.3% < 0.001
SSRI/SNRI 34.9% 15.3% 36.6%  
Tricyclic antidepressants 9.2% 6.8% 9.5%  
Antiepileptics 2.8% 1.7% 2.9%  
Other medication 3.7% 3.4% 3.7%  
  1. Values are expressed as arithmetic mean (SD).
  2. NS = not significant; SSRI/SNRI = selective serotonin reuptake inhibitors/mixed action selective serotonin reuptake inhibitors or noradrenergics.